MYCN and neuroblastoma: Nine patients (39.1%) did not harbor gains in chromosome 2p spanning MYCN. Two had 11q deletion which, as reported in neuroblastoma, may be mutually exclusive [31]; two had concomitant 17q gain and 19q loss; and two showed loss in 19q and 21q, respectively.